ClinicalTrials.gg

Low Back Pain clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 2,927 studies for Low Back Pain across more than 10 countries. 580 are recruiting or about to start. 2,528 of them are mainly about Low Back Pain (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17.

ClinicalTrials.gov finds 3,498 studies for Low Back Pain. How that becomes 2,923 here

This page counts the studies the registry files under Low Back Pain, and those it files under no condition that list Low Back Painthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count

  1. 3,498Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −299List Low Back Pain as a condition, but the registry did not file them under itMost often written as “Chronic Low Back Pain” (107), “Chronic Low-back Pain” (78), and “Chronic Low Back Pain (CLBP)” (20). The registry filed them under other conditions only, most often Pain (64) and Chronic Pain (58).
  3. −283Match it another way209 name it in the title, 19 in a keyword, and 55 by a synonym or other text the search reads.
  4. 2,916Counted here and found by its search543 of them list Low Back Pain in their own words; the registry filed them under no condition.
  5. +7
    Counted here, but its search does not find them
  6. 2,923The count on this page

Status

Completed
1,734
Status unknown
357
Recruiting
333
Not yet recruiting
201
Terminated
102
Active, not recruiting
82

Phase

Phase 3
169
Phase 2
144
Phase 4
120
Phase 1
63
Early Phase 1
13

Where

United States
712
Turkey
295
Pakistan
223
Spain
168
Brazil
125
Egypt
121

Who develops what

Add Low Back Pain to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 4 programs from 4 companies, 1 with this as their studies’ main aim; 1 with a live phase 3 study; 1 primary completion in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
IbuprofenRecent, limited
Evidence
  • NCT05222724 · Angelini Pharma · Phase 4 · comparator · “Brufen” · registered Jan 2022
  • NCT01028079 · Bayer · Phase 3 · comparator · “Ibuprofen” · registered Dec 2009
Pfizer13% of its industry studiesUS: off-patent, 81 generics marketedEU: off-patent, 1 generic authorized11 study
RLD2401Recent, limited
Evidence
  • NCT06595004 · Hanmi Pharmaceutical Company Limited · Phase 3 · comparator · “RLD2401” · registered Sep 2024
—11 study
Analgesics, OpioidRecent, limited
Evidence
  • NCT05610813 · Vertanical GmbH · Phase 3 · comparator · “Opioid therapy” · registered Nov 2022
—11 study

3 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 4 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Apr 2027 est.LY4065967 · Eli Lilly and Company · Phase 2 named, not the main aimNCT07641504 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain — primary endpoint: Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) · 150 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Low Back Pain studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Corticosteroids 3 open · NSAIDs 2 open · Local anesthetics 1 open · SNRIs 1 open · Opioid antagonists 1 open

Coming up

180studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger. 8 (2%) take children under 18. 17 (5%) are for women only and 2 (1%) for men only; 46 (14%) take healthy volunteers.

Recruiting studies that take each age, of 332
AgeWomenMen
105 (2%)5 (2%)
18250 (75%)244 (73%)
30309 (93%)297 (89%)
40308 (93%)297 (89%)
50270 (81%)265 (80%)
65222 (67%)221 (67%)
75137 (41%)137 (41%)
85110 (33%)110 (33%)

Across all 2,926 studies, recruiting or not: 65% stop at 75 or younger and 53% at 65; 4% take children; 6% are for women only and 1% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Low Back Pain studies take

Of 35 phase 3 interventional studies under Low Back Pain, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 213 mo11–43 · 33 studies——
Phase 331 mo16–40 · 35 studies——
Phase 420 mo14–53 · 33 studies——
Interventional, no phase11 mo5–27 · 1,288 studies19 mo12–44 · 55 studies11 mo4–26 · 1,233 studies
Observational24 mo10–48 · 186 studies—24 mo10–48 · 176 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered20

Show 15 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,927. Browse all 2,927 → or search them.